These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
684 related articles for article (PubMed ID: 12489846)
21. The resorcylic acid lactone hypothemycin selectively inhibits the mitogen-activated protein kinase kinase-extracellular signal-regulated kinase pathway in cells. Fukazawa H; Ikeda Y; Fukuyama M; Suzuki T; Hori H; Okuda T; Uehara Y Biol Pharm Bull; 2010; 33(2):168-73. PubMed ID: 20118535 [TBL] [Abstract][Full Text] [Related]
22. Assessment of cell-signaling pathways in the regulation of mammalian target of rapamycin (mTOR) by amino acids in rat adipocytes. Pham PT; Heydrick SJ; Fox HL; Kimball SR; Jefferson LS; Lynch CJ J Cell Biochem; 2000 Sep; 79(3):427-41. PubMed ID: 10972980 [TBL] [Abstract][Full Text] [Related]
23. Roles of human epidermal growth factor receptor 2, c-jun NH2-terminal kinase, phosphoinositide 3-kinase, and p70 S6 kinase pathways in regulation of cyclin G2 expression in human breast cancer cells. Le XF; Arachchige-Don AS; Mao W; Horne MC; Bast RC Mol Cancer Ther; 2007 Nov; 6(11):2843-57. PubMed ID: 18025271 [TBL] [Abstract][Full Text] [Related]
24. Extracellular ATP-induced proliferation of adventitial fibroblasts requires phosphoinositide 3-kinase, Akt, mammalian target of rapamycin, and p70 S6 kinase signaling pathways. Gerasimovskaya EV; Tucker DA; Weiser-Evans M; Wenzlau JM; Klemm DJ; Banks M; Stenmark KR J Biol Chem; 2005 Jan; 280(3):1838-48. PubMed ID: 15522879 [TBL] [Abstract][Full Text] [Related]
25. Cross-talk between the ERK and p70 S6 kinase (S6K) signaling pathways. MEK-dependent activation of S6K2 in cardiomyocytes. Wang L; Gout I; Proud CG J Biol Chem; 2001 Aug; 276(35):32670-7. PubMed ID: 11431469 [TBL] [Abstract][Full Text] [Related]
26. Differential activation mechanisms of Erk-1/2 and p70(S6K) by glucose in pancreatic beta-cells. Briaud I; Lingohr MK; Dickson LM; Wrede CE; Rhodes CJ Diabetes; 2003 Apr; 52(4):974-83. PubMed ID: 12663469 [TBL] [Abstract][Full Text] [Related]
27. Role of the phosphatidylinositol 3-kinase/Akt and mTOR/P70S6-kinase pathways in the proliferation and apoptosis in multiple myeloma. Pene F; Claessens YE; Muller O; Viguié F; Mayeux P; Dreyfus F; Lacombe C; Bouscary D Oncogene; 2002 Sep; 21(43):6587-97. PubMed ID: 12242656 [TBL] [Abstract][Full Text] [Related]
28. Proliferation of IL-6-independent multiple myeloma does not require the activity of extracellular signal-regulated kinases (ERK1/2). Zhang B; Fenton RG J Cell Physiol; 2002 Oct; 193(1):42-54. PubMed ID: 12209879 [TBL] [Abstract][Full Text] [Related]
29. Prion formation correlates with activation of translation-regulating protein 4E-BP and neuronal transcription factor Elk1. Allard EK; Grujic M; Fisone G; Kristensson K Neurobiol Dis; 2013 Oct; 58():116-22. PubMed ID: 23742760 [TBL] [Abstract][Full Text] [Related]
30. Activation of mammalian target of rapamycin in transformed B lymphocytes is nutrient dependent but independent of Akt, mitogen-activated protein kinase/extracellular signal-regulated kinase kinase, insulin growth factor-I, and serum. Wlodarski P; Kasprzycka M; Liu X; Marzec M; Robertson ES; Slupianek A; Wasik MA Cancer Res; 2005 Sep; 65(17):7800-8. PubMed ID: 16140948 [TBL] [Abstract][Full Text] [Related]
31. MEK/ERK inhibitor U0126 affects in vitro and in vivo growth of embryonal rhabdomyosarcoma. Marampon F; Bossi G; Ciccarelli C; Di Rocco A; Sacchi A; Pestell RG; Zani BM Mol Cancer Ther; 2009 Mar; 8(3):543-51. PubMed ID: 19258428 [TBL] [Abstract][Full Text] [Related]
32. Nitric oxide increases p21(Waf1/Cip1) expression by a cGMP-dependent pathway that includes activation of extracellular signal-regulated kinase and p70(S6k). Gu M; Lynch J; Brecher P J Biol Chem; 2000 Apr; 275(15):11389-96. PubMed ID: 10753954 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of insulin signaling and adipogenesis by rapamycin: effect on phosphorylation of p70 S6 kinase vs eIF4E-BP1. El-Chaâr D; Gagnon A; Sorisky A Int J Obes Relat Metab Disord; 2004 Feb; 28(2):191-8. PubMed ID: 14970836 [TBL] [Abstract][Full Text] [Related]
34. Hydrogen peroxide mediates arsenite activation of p70(s6k) and extracellular signal-regulated kinase. Jung DK; Bae GU; Kim YK; Han SH; Choi WS; Kang H; Seo DW; Lee HY; Cho EJ; Lee HW; Han JW Exp Cell Res; 2003 Oct; 290(1):144-54. PubMed ID: 14516795 [TBL] [Abstract][Full Text] [Related]
35. Effects of rapamycin on cell proliferation and phosphorylation of mTOR and p70(S6K) in HepG2 and HepG2 cells overexpressing constitutively active Akt/PKB. Varma S; Khandelwal RL Biochim Biophys Acta; 2007 Jan; 1770(1):71-8. PubMed ID: 16952420 [TBL] [Abstract][Full Text] [Related]
36. Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors. Marampon F; Ciccarelli C; Zani BM Mol Cancer; 2006 Aug; 5():31. PubMed ID: 16899113 [TBL] [Abstract][Full Text] [Related]
37. Phorbol ester phorbol-12-myristate-13-acetate promotes anchorage-independent growth and survival of melanomas through MEK-independent activation of ERK1/2. Jørgensen K; Skrede M; Cruciani V; Mikalsen SO; Slipicevic A; Flørenes VA Biochem Biophys Res Commun; 2005 Apr; 329(1):266-74. PubMed ID: 15721302 [TBL] [Abstract][Full Text] [Related]
38. The MEK/ERK pathway mediates COX-2-selective NSAID-induced apoptosis and induced COX-2 protein expression in colorectal carcinoma cells. Elder DJ; Halton DE; Playle LC; Paraskeva C Int J Cancer; 2002 May; 99(3):323-7. PubMed ID: 11992399 [TBL] [Abstract][Full Text] [Related]
39. Signal transduction pathways involved in phosphorylation and activation of p70S6K following exposure to UVA irradiation. Zhang Y; Dong Z; Nomura M; Zhong S; Chen N; Bode AM; Dong Z J Biol Chem; 2001 Jun; 276(24):20913-23. PubMed ID: 11279232 [TBL] [Abstract][Full Text] [Related]
40. The combination of rapamycin and MAPK inhibitors enhances the growth inhibitory effect on Nara-H cells. Nakamura O; Hitora T; Yamagami Y; Mori M; Nishimura H; Horie R; Yamaguchi K; Yamamoto T Int J Mol Med; 2014 Jun; 33(6):1491-7. PubMed ID: 24676456 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]